SlideShare a Scribd company logo
Heterologous Expression in
E. coli & Yeast
Tassanee Lerksuthirat
Research Center, Faculty of Medicine,
Ramathibodi Hospital, Mahidol University
MIC421 Applied Microbiology, KMUTT ~ 9 February 2016
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Products using heterologous expression
• Human therapeutic agents
– Human insulin
– Human epidermal growth factor
• Diagnostic
– HIV-antigen
• Vaccine
– HIV-1 envelope protein
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Products using heterologous expression
• Human therapeutic agents
– Human insulin
– Human epidermal growth factor
• Diagnostic
– HIV-antigen
• Vaccine
– HIV-1 envelope protein
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Recombinant DNA technology
• Cohen, et al. (1973)
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Recombinant DNA technology
Stanley N. Cohen PNAS 2013;110:15521-15529
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Workflow for heterologous expression
General consideration
• Choice of host organism
• Cloning and strain development
• Transcription
• Translation and 3D-structure
• Fate of synthesized
• Recovery
• Availability of the resources
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Comparison of expression systems
Parameter E. coli Yeast
Cell growth Rapid Some what slow
Complexity of growth medium Minimum Minimum
Cost of growth medium Low Some what high
Expression level High Low to High
Extracellular expression Periplasm Medium
Manipulation Easy Some what hard
Posttranslational modifications
Protein folding Usually required May required
N-linked glycosylation None High in mannose
O-linked glycosylation No Yes
Phosphorylation No Yes
Acetylation No Yes
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Example research; E. coli
Gaastra, W., et al. (2010), De Cock A.W., et al. (1987)
Vanittanakom N., et al. (2004), Mendoza L., et al. (1993)
Krajaejun T., et al. (2004), Hanson R. R., et al. (2008)
Picture from Dr. Boonmee Sathapatayavongs http://pythium.pavlab.com/subpage3.html
• Elicitin025
– Putative virulence factor
– Antibody production
– Immunological response
– Potentially diagnostic test
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
What is the characteristic of ELI025?
• Elicitin025
– 112 amino acids
– 10 kDa (W/O SP)
– Signal peptide
– Disulfide bonds
– O-, N- glycosylation
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Plasmid or Vector?
• Plasmid
– Extrachromosomal DNA
– Circular double-stranded
DNA
– Origin of replication (ORI)
– Mainly found in bacteria &
occasionally in yeast
• Vector
– Vehicle plasmid for
maintaining cloned gene
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Plasmid or Vector?
• Vector element
– Origin of replication (ORI)
– Promoter
– Multiple cloning site (MSC)
– Selectable marker
– Antibiotic resistance gene
– Primer binding site
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Plasmid or Vector?
• Selectable marker
– Antibiotic resistant
– Amp, Kan
• Promoter
– Strong
– Regulatable
– Prevent energy drain
• Fusion protein
– Purification
– Expression detection
– His-tag, GST-tag
• Signal sequences
– Periplasmic
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Plasmid or Vector?
• ELI025
– pET28b
– T7/lac promoter
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Plasmid or Vector?
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Host?
Strain Description Use Antibiotic Supplier
BL21 (DE3) deficient in lon and
ompT proteases
general purpose
expression host
none Novagen
Rosetta (DE3) lactose permease
(lacY) mutant,
deficient in lon and
ompT proteases;
contains plasmid
encoding argU, argW,
glyT, IleX, leuW, metT,
proL, thrT,
thrU, and tyrU
expression host;
allows expression of
genes encoding
tRNAs for rare
argenine codons
AGA, AGG, and CGA,
glycine codon GGA,
isoleucine codon
AUA, leucine codon
CUA, and proline
codon CCC
Cam Novagen
Origami (DE3) trxB and gor mutant expression host;
disulfide bond
formation in
cytoplasm
Kan Novagen
Rosetta-gami (DE3) Rosetta + Origami (DE3) Cam + Kan Novagen
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Example research; Yeast
• PAN112
– Putative virulence factor
– Antibody production
– Immunological response
– Potentially diagnostic test
– Unsuccessful in E. coli expression
• Characteristic
– Signal peptide
– Contain 8 disulfide bonds
– N-glycosylation
– 34 kDa (W/O SP)
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Example research; Yeast
• Available commercial system
– Saccharomyces cerevisiae
– Pichia pastoris
• Disadvantages of S.cerevisiae expression system
– Instability of plasmids
– Hyperglycosylation
– May secrete protein trapped in periplasmic space
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Example research; Yeast
• Expression in P. pastoris
– work under strong inducible
promoter
• AOX1 (alcohol oxidase 1)
• Regulated by methanol
• 30% of total soluble
protein
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Example research; Yeast
• Expression of in P. pastoris
– Avoid problems of plasmid instability; vector integrated into
the host chromosome
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Example research; Yeast
• Expression of PAN112 in P. pastoris
pPICZalphaA-PAN112
4474bp
Zeo(R)
alpha-factor signal peptide
c-myc epitope
6xHis
PAN112
alpha-factor primer
5' AOX1 primer
3' AOX1 primer
AOX1 promoter
TEF1 promoter
EM7 promoter
pUC origin
CYC1 transcription terminator
AOX1 transcription terminator
DraI(4310)
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Example research; Yeast
• Expression of PAN112 in P. pastoris
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Example research; Yeast
• Expression of PAN112 in P. pastoris
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Example research; Yeast
• Expression of PAN112 in P. pastoris
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
Heterologous expression
• Identify the study purpose
• Choice of host organism
– E. coli or Yeast
• Cloning and strain development
– Targeted protein characteristic
– Codon usage
• Post-modificationRecovery
– Purification system
• Availability of the resources
– Purchase
– Collaborate
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t
References
• Cohen, S. N., A. C. Chang, H. W. Boyer and R. B. Helling (1973). "Construction of
biologically functional bacterial plasmids in vitro." Proc Natl Acad Sci U S A 70(11):
3240-3244.
• Cohen, S. N. (2013). "DNA cloning: a personal view after 40 years." Proc Natl Acad
Sci U S A 110(39): 15521-15529.
• Fernandez, J. M. and J. P. Hoeffler (1999). Gene expression systems : using nature
for the art of expression, San Diego, Calif. : Academic Press, c1999.
• Glick, B. R., T. L. Delovitch and C. L. Patten (2014). Medical biotechnology.
• Glick, B. R., J. J. Pasternak and C. L. Patten (2010). "Molecular biotechnology :
principles and applications of recombinant DNA.“
• https://www.addgene.org/
• http://www.merckmillipore.com/
• http://www.thermofisher.com/th/en/home.html
T
a
s
s
a
n
e
e
L
e
r
k
s
u
t
h
i
r
a
t

More Related Content

PPTX
Expression vectors
PDF
Animal viral vector
PPTX
Cell synchronization
PDF
pUC18 vector
PPTX
Binary Vector, By KK Sahu sir
PDF
Vector engineering and codon optimization
PPTX
cDNA synthesis
PPTX
Phagemid vector
Expression vectors
Animal viral vector
Cell synchronization
pUC18 vector
Binary Vector, By KK Sahu sir
Vector engineering and codon optimization
cDNA synthesis
Phagemid vector

What's hot (20)

PPTX
cDNA Library Construction
PPTX
Protein purification
PPTX
PPTX
P bluescript
PPTX
Yeast two hybrid system
PPTX
Strategies for Recombinant protein production in E.coli
PPTX
Pyrosequencing
PPTX
S1 Nuclease Mapping
PPTX
YEAST TWO HYBRID SYSTEM
PPTX
Cosmid
PPT
PPTX
Colony hybridization technique
PPTX
Lectut btn-202-ppt-l23. labeling techniques for nucleic acids
PPTX
P gem3 z example of puc vector
PPTX
Comparative genomics
PPTX
Site directed mutagenesis
PPTX
Protein dna interactions
PPTX
M13 phage
DOCX
PPTX
Snp and its role in diseases
cDNA Library Construction
Protein purification
P bluescript
Yeast two hybrid system
Strategies for Recombinant protein production in E.coli
Pyrosequencing
S1 Nuclease Mapping
YEAST TWO HYBRID SYSTEM
Cosmid
Colony hybridization technique
Lectut btn-202-ppt-l23. labeling techniques for nucleic acids
P gem3 z example of puc vector
Comparative genomics
Site directed mutagenesis
Protein dna interactions
M13 phage
Snp and its role in diseases
Ad

Similar to Heterologous expression lecture (20)

PPTX
Eukayotic expression - vimmi.
PPT
EXPRESSION SYSTEMS.ppt
PPTX
Expression system final
DOCX
Expression systems
PPTX
cloning and expression system in yeast
PPT
PBIO4500 Protein Therapeutics.ppt
PPTX
Exprssion vector
PPT
同玩節海報事件
PPTX
Heterologous proteins
PDF
Fulltext
PDF
Heterologous Gene Expression in E coli Methods and Protocols 1st Edition Evel...
PPTX
Promoters used in expression vectors
PDF
Heterologous Gene Expression in E coli Methods and Protocols 1st Edition Evel...
PPTX
Expression systems
PDF
gene cloning in eukaryotes (gene transfer).pdf
PPTX
Yeast Expression system class 3.pptx
PPT
Restrictions endonuclease and vectors for gene cloning
PDF
BIO Philadelphia yeast expression 2005
DOC
Recombinant dna
PDF
Heterologous Gene Expression In Ecoli Methods And Protocols 1st Nicola A Burg...
Eukayotic expression - vimmi.
EXPRESSION SYSTEMS.ppt
Expression system final
Expression systems
cloning and expression system in yeast
PBIO4500 Protein Therapeutics.ppt
Exprssion vector
同玩節海報事件
Heterologous proteins
Fulltext
Heterologous Gene Expression in E coli Methods and Protocols 1st Edition Evel...
Promoters used in expression vectors
Heterologous Gene Expression in E coli Methods and Protocols 1st Edition Evel...
Expression systems
gene cloning in eukaryotes (gene transfer).pdf
Yeast Expression system class 3.pptx
Restrictions endonuclease and vectors for gene cloning
BIO Philadelphia yeast expression 2005
Recombinant dna
Heterologous Gene Expression In Ecoli Methods And Protocols 1st Nicola A Burg...
Ad

More from Tassanee Lerksuthirat (20)

PDF
Chemotherapy spill kit_250727_112602.pdf
PDF
JCMS2025_250725_note_4medicalinstitues_conference
PDF
JCMS2025_250724_note_4medicalinstitues_conference
PDF
JCMS2025_250723_note_4medicalinstitues_conference
PDF
แนวทางการเขียนกิติกรรมประกาศของศูนย์ถ่ายภาพเพื่องานวิจัยทางวิทยาศาสตร์.pdf
PDF
การอบรมพัฒนาศักยภาพนักวิจัยด้านการบูรณาการข้ามศาสตร์เพื่อการพัฒนาที่ยั่งยื.pdf
PDF
ระเบียบการใช้กล้อง Axio Imager 2 (Fully Motorized) ver2.pdf
PDF
Mahidol_Change_Agent_Note_2025-06-27-29_MUSEF
PDF
Note: Symposium on “mRNA as genetic medicines: the next-generation biologics ...
PDF
ประกาศ สนง.วิจัยฯ แนวปฏิบัติกรณีช่างจากบริษัทภายนอกเข้าปฏิบัติงาน__เริ่ม 12มี...
PDF
SIM ZEISS_Demonstration at Chulalongkorn University
PDF
แนวทางการเบิกค่าทันตกรรมจากประกันสังคม_SSO_online_reimbursement
PDF
การขอใบรับรองนักวิจัยที่ดำเนินงานในห้องปฏิบัติการที่เกี่ยวข้องกับสารเคมี.pdf
PDF
RIAC 2024_240910_162240_conference_note.pdf
PDF
Research integrity_note_DrYongPoovorawan.pdf
PDF
ระเบียบการใช้กล้อง Axio Imager 2 (Fully Motorized).pdf
PDF
2024_Health_risk_assessment_plus_note.pdf
PDF
Plan-expenditure_edcation_support_MM_2567_goverment_budget
PDF
People-expenditure_2567_goverment_budget
PDF
MHESI fair_PMUB_Workshop_Global_Partnership_AI.pdf
Chemotherapy spill kit_250727_112602.pdf
JCMS2025_250725_note_4medicalinstitues_conference
JCMS2025_250724_note_4medicalinstitues_conference
JCMS2025_250723_note_4medicalinstitues_conference
แนวทางการเขียนกิติกรรมประกาศของศูนย์ถ่ายภาพเพื่องานวิจัยทางวิทยาศาสตร์.pdf
การอบรมพัฒนาศักยภาพนักวิจัยด้านการบูรณาการข้ามศาสตร์เพื่อการพัฒนาที่ยั่งยื.pdf
ระเบียบการใช้กล้อง Axio Imager 2 (Fully Motorized) ver2.pdf
Mahidol_Change_Agent_Note_2025-06-27-29_MUSEF
Note: Symposium on “mRNA as genetic medicines: the next-generation biologics ...
ประกาศ สนง.วิจัยฯ แนวปฏิบัติกรณีช่างจากบริษัทภายนอกเข้าปฏิบัติงาน__เริ่ม 12มี...
SIM ZEISS_Demonstration at Chulalongkorn University
แนวทางการเบิกค่าทันตกรรมจากประกันสังคม_SSO_online_reimbursement
การขอใบรับรองนักวิจัยที่ดำเนินงานในห้องปฏิบัติการที่เกี่ยวข้องกับสารเคมี.pdf
RIAC 2024_240910_162240_conference_note.pdf
Research integrity_note_DrYongPoovorawan.pdf
ระเบียบการใช้กล้อง Axio Imager 2 (Fully Motorized).pdf
2024_Health_risk_assessment_plus_note.pdf
Plan-expenditure_edcation_support_MM_2567_goverment_budget
People-expenditure_2567_goverment_budget
MHESI fair_PMUB_Workshop_Global_Partnership_AI.pdf

Recently uploaded (20)

PPTX
1st Inaugural Professorial Lecture held on 19th February 2020 (Governance and...
PDF
Yogi Goddess Pres Conference Studio Updates
PPTX
Microbial diseases, their pathogenesis and prophylaxis
PPTX
Pharmacology of Heart Failure /Pharmacotherapy of CHF
PDF
VCE English Exam - Section C Student Revision Booklet
PPTX
PPT- ENG7_QUARTER1_LESSON1_WEEK1. IMAGERY -DESCRIPTIONS pptx.pptx
PDF
Black Hat USA 2025 - Micro ICS Summit - ICS/OT Threat Landscape
PDF
A systematic review of self-coping strategies used by university students to ...
PPTX
Introduction-to-Literarature-and-Literary-Studies-week-Prelim-coverage.pptx
PDF
STATICS OF THE RIGID BODIES Hibbelers.pdf
PDF
O7-L3 Supply Chain Operations - ICLT Program
PDF
A GUIDE TO GENETICS FOR UNDERGRADUATE MEDICAL STUDENTS
PPTX
202450812 BayCHI UCSC-SV 20250812 v17.pptx
PDF
GENETICS IN BIOLOGY IN SECONDARY LEVEL FORM 3
PPTX
Final Presentation General Medicine 03-08-2024.pptx
PDF
Anesthesia in Laparoscopic Surgery in India
PDF
RTP_AR_KS1_Tutor's Guide_English [FOR REPRODUCTION].pdf
PDF
OBE - B.A.(HON'S) IN INTERIOR ARCHITECTURE -Ar.MOHIUDDIN.pdf
PDF
Weekly quiz Compilation Jan -July 25.pdf
PPTX
Orientation - ARALprogram of Deped to the Parents.pptx
1st Inaugural Professorial Lecture held on 19th February 2020 (Governance and...
Yogi Goddess Pres Conference Studio Updates
Microbial diseases, their pathogenesis and prophylaxis
Pharmacology of Heart Failure /Pharmacotherapy of CHF
VCE English Exam - Section C Student Revision Booklet
PPT- ENG7_QUARTER1_LESSON1_WEEK1. IMAGERY -DESCRIPTIONS pptx.pptx
Black Hat USA 2025 - Micro ICS Summit - ICS/OT Threat Landscape
A systematic review of self-coping strategies used by university students to ...
Introduction-to-Literarature-and-Literary-Studies-week-Prelim-coverage.pptx
STATICS OF THE RIGID BODIES Hibbelers.pdf
O7-L3 Supply Chain Operations - ICLT Program
A GUIDE TO GENETICS FOR UNDERGRADUATE MEDICAL STUDENTS
202450812 BayCHI UCSC-SV 20250812 v17.pptx
GENETICS IN BIOLOGY IN SECONDARY LEVEL FORM 3
Final Presentation General Medicine 03-08-2024.pptx
Anesthesia in Laparoscopic Surgery in India
RTP_AR_KS1_Tutor's Guide_English [FOR REPRODUCTION].pdf
OBE - B.A.(HON'S) IN INTERIOR ARCHITECTURE -Ar.MOHIUDDIN.pdf
Weekly quiz Compilation Jan -July 25.pdf
Orientation - ARALprogram of Deped to the Parents.pptx

Heterologous expression lecture

  • 1. Heterologous Expression in E. coli & Yeast Tassanee Lerksuthirat Research Center, Faculty of Medicine, Ramathibodi Hospital, Mahidol University MIC421 Applied Microbiology, KMUTT ~ 9 February 2016 T a s s a n e e L e r k s u t h i r a t
  • 2. Products using heterologous expression • Human therapeutic agents – Human insulin – Human epidermal growth factor • Diagnostic – HIV-antigen • Vaccine – HIV-1 envelope protein T a s s a n e e L e r k s u t h i r a t
  • 3. Products using heterologous expression • Human therapeutic agents – Human insulin – Human epidermal growth factor • Diagnostic – HIV-antigen • Vaccine – HIV-1 envelope protein T a s s a n e e L e r k s u t h i r a t
  • 4. Recombinant DNA technology • Cohen, et al. (1973) T a s s a n e e L e r k s u t h i r a t
  • 5. Recombinant DNA technology Stanley N. Cohen PNAS 2013;110:15521-15529 T a s s a n e e L e r k s u t h i r a t
  • 6. Workflow for heterologous expression General consideration • Choice of host organism • Cloning and strain development • Transcription • Translation and 3D-structure • Fate of synthesized • Recovery • Availability of the resources T a s s a n e e L e r k s u t h i r a t
  • 7. Comparison of expression systems Parameter E. coli Yeast Cell growth Rapid Some what slow Complexity of growth medium Minimum Minimum Cost of growth medium Low Some what high Expression level High Low to High Extracellular expression Periplasm Medium Manipulation Easy Some what hard Posttranslational modifications Protein folding Usually required May required N-linked glycosylation None High in mannose O-linked glycosylation No Yes Phosphorylation No Yes Acetylation No Yes T a s s a n e e L e r k s u t h i r a t
  • 8. Example research; E. coli Gaastra, W., et al. (2010), De Cock A.W., et al. (1987) Vanittanakom N., et al. (2004), Mendoza L., et al. (1993) Krajaejun T., et al. (2004), Hanson R. R., et al. (2008) Picture from Dr. Boonmee Sathapatayavongs http://pythium.pavlab.com/subpage3.html • Elicitin025 – Putative virulence factor – Antibody production – Immunological response – Potentially diagnostic test T a s s a n e e L e r k s u t h i r a t
  • 9. What is the characteristic of ELI025? • Elicitin025 – 112 amino acids – 10 kDa (W/O SP) – Signal peptide – Disulfide bonds – O-, N- glycosylation T a s s a n e e L e r k s u t h i r a t
  • 10. Plasmid or Vector? • Plasmid – Extrachromosomal DNA – Circular double-stranded DNA – Origin of replication (ORI) – Mainly found in bacteria & occasionally in yeast • Vector – Vehicle plasmid for maintaining cloned gene T a s s a n e e L e r k s u t h i r a t
  • 11. Plasmid or Vector? • Vector element – Origin of replication (ORI) – Promoter – Multiple cloning site (MSC) – Selectable marker – Antibiotic resistance gene – Primer binding site T a s s a n e e L e r k s u t h i r a t
  • 12. Plasmid or Vector? • Selectable marker – Antibiotic resistant – Amp, Kan • Promoter – Strong – Regulatable – Prevent energy drain • Fusion protein – Purification – Expression detection – His-tag, GST-tag • Signal sequences – Periplasmic T a s s a n e e L e r k s u t h i r a t
  • 13. Plasmid or Vector? • ELI025 – pET28b – T7/lac promoter T a s s a n e e L e r k s u t h i r a t
  • 15. Host? Strain Description Use Antibiotic Supplier BL21 (DE3) deficient in lon and ompT proteases general purpose expression host none Novagen Rosetta (DE3) lactose permease (lacY) mutant, deficient in lon and ompT proteases; contains plasmid encoding argU, argW, glyT, IleX, leuW, metT, proL, thrT, thrU, and tyrU expression host; allows expression of genes encoding tRNAs for rare argenine codons AGA, AGG, and CGA, glycine codon GGA, isoleucine codon AUA, leucine codon CUA, and proline codon CCC Cam Novagen Origami (DE3) trxB and gor mutant expression host; disulfide bond formation in cytoplasm Kan Novagen Rosetta-gami (DE3) Rosetta + Origami (DE3) Cam + Kan Novagen T a s s a n e e L e r k s u t h i r a t
  • 16. Example research; Yeast • PAN112 – Putative virulence factor – Antibody production – Immunological response – Potentially diagnostic test – Unsuccessful in E. coli expression • Characteristic – Signal peptide – Contain 8 disulfide bonds – N-glycosylation – 34 kDa (W/O SP) T a s s a n e e L e r k s u t h i r a t
  • 17. Example research; Yeast • Available commercial system – Saccharomyces cerevisiae – Pichia pastoris • Disadvantages of S.cerevisiae expression system – Instability of plasmids – Hyperglycosylation – May secrete protein trapped in periplasmic space T a s s a n e e L e r k s u t h i r a t
  • 18. Example research; Yeast • Expression in P. pastoris – work under strong inducible promoter • AOX1 (alcohol oxidase 1) • Regulated by methanol • 30% of total soluble protein T a s s a n e e L e r k s u t h i r a t
  • 19. Example research; Yeast • Expression of in P. pastoris – Avoid problems of plasmid instability; vector integrated into the host chromosome T a s s a n e e L e r k s u t h i r a t
  • 20. Example research; Yeast • Expression of PAN112 in P. pastoris pPICZalphaA-PAN112 4474bp Zeo(R) alpha-factor signal peptide c-myc epitope 6xHis PAN112 alpha-factor primer 5' AOX1 primer 3' AOX1 primer AOX1 promoter TEF1 promoter EM7 promoter pUC origin CYC1 transcription terminator AOX1 transcription terminator DraI(4310) T a s s a n e e L e r k s u t h i r a t
  • 21. Example research; Yeast • Expression of PAN112 in P. pastoris T a s s a n e e L e r k s u t h i r a t
  • 22. Example research; Yeast • Expression of PAN112 in P. pastoris T a s s a n e e L e r k s u t h i r a t
  • 23. Example research; Yeast • Expression of PAN112 in P. pastoris T a s s a n e e L e r k s u t h i r a t
  • 24. Heterologous expression • Identify the study purpose • Choice of host organism – E. coli or Yeast • Cloning and strain development – Targeted protein characteristic – Codon usage • Post-modificationRecovery – Purification system • Availability of the resources – Purchase – Collaborate T a s s a n e e L e r k s u t h i r a t
  • 25. References • Cohen, S. N., A. C. Chang, H. W. Boyer and R. B. Helling (1973). "Construction of biologically functional bacterial plasmids in vitro." Proc Natl Acad Sci U S A 70(11): 3240-3244. • Cohen, S. N. (2013). "DNA cloning: a personal view after 40 years." Proc Natl Acad Sci U S A 110(39): 15521-15529. • Fernandez, J. M. and J. P. Hoeffler (1999). Gene expression systems : using nature for the art of expression, San Diego, Calif. : Academic Press, c1999. • Glick, B. R., T. L. Delovitch and C. L. Patten (2014). Medical biotechnology. • Glick, B. R., J. J. Pasternak and C. L. Patten (2010). "Molecular biotechnology : principles and applications of recombinant DNA.“ • https://www.addgene.org/ • http://www.merckmillipore.com/ • http://www.thermofisher.com/th/en/home.html T a s s a n e e L e r k s u t h i r a t